Correlation Between BioNTech and KAUFMAN ET

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioNTech and KAUFMAN ET at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and KAUFMAN ET into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioNTech SE and KAUFMAN ET BROAD, you can compare the effects of market volatilities on BioNTech and KAUFMAN ET and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of KAUFMAN ET. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and KAUFMAN ET.

Diversification Opportunities for BioNTech and KAUFMAN ET

-0.62
  Correlation Coefficient

Excellent diversification

The 3 months correlation between BioNTech and KAUFMAN is -0.62. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and KAUFMAN ET BROAD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on KAUFMAN ET BROAD and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with KAUFMAN ET. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of KAUFMAN ET BROAD has no effect on the direction of BioNTech i.e., BioNTech and KAUFMAN ET go up and down completely randomly.

Pair Corralation between BioNTech and KAUFMAN ET

Assuming the 90 days trading horizon BioNTech SE is expected to generate 2.31 times more return on investment than KAUFMAN ET. However, BioNTech is 2.31 times more volatile than KAUFMAN ET BROAD. It trades about 0.11 of its potential returns per unit of risk. KAUFMAN ET BROAD is currently generating about -0.08 per unit of risk. If you would invest  9,940  in BioNTech SE on October 7, 2024 and sell it today you would earn a total of  1,320  from holding BioNTech SE or generate 13.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BioNTech SE  vs.  KAUFMAN ET BROAD

 Performance 
       Timeline  
BioNTech SE 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound basic indicators, BioNTech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
KAUFMAN ET BROAD 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days KAUFMAN ET BROAD has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, KAUFMAN ET is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

BioNTech and KAUFMAN ET Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioNTech and KAUFMAN ET

The main advantage of trading using opposite BioNTech and KAUFMAN ET positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, KAUFMAN ET can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in KAUFMAN ET will offset losses from the drop in KAUFMAN ET's long position.
The idea behind BioNTech SE and KAUFMAN ET BROAD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins